2289.HK实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (25 Jun 2024 @ 14:25):
No signals from the correlation tool

Stats
今日成交量	3 000
平均成交量	71 966
市值	928.80M
EPS	HKD0.230 ( Q4 \| 2023-12-31 )
Last Dividend	HKD0.499 ( 2023-06-29 )
Next Dividend	HKD0 ( N/A )
P/E	16.86 (Sector) 14.27 (Industry) 0
ATR14	HKD0 (0.00%)

0673.HK -3.06%

0718.HK 15.15%

1099.HK 0.97%

1931.HK 0.00%

2192.HK 0.00%

2289.HK 0.00%

2607.HK 0.86%

相关性 (AI algo v.1.1b): Paired value (算法实时跟踪最相关股票的变化并提供即时更新)

Charmacy Pharmaceutical 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Charmacy Pharmaceutical 财务报表

Annual	2023
营收:	HKD4.40B
毛利润:	HKD292.74M (6.65 %)
EPS:	HKD0.480

FY	2023
营收:	HKD4.40B
毛利润:	HKD292.74M (6.65 %)
EPS:	HKD0.480

FY	2022
营收:	HKD4.18B
毛利润:	HKD268.61M (6.43 %)
EPS:	HKD0.840

FY	2021
营收:	HKD3.79B
毛利润:	HKD237.22M (6.25 %)
EPS:	HKD0.221

Financial Reports:

No articles found.

Charmacy Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.949 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Charmacy Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 5.24 - average (41.79%) | Divividend Growth Potential Score: 3.37 - Decrease likely (32.62%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.229	2016-11-14
Last Dividend	HKD0.499	2023-06-29
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	9	--
Total Paid Out	HKD2.57	--
Avg. Dividend % Per Year	0.00%	--
Score	1.88	--
Div. Sustainability Score	5.24
Div.Growth Potential Score	3.37
Div. Directional Score	4.30	--

Next Divdend (Est)
(2024-10-07)

HKD0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

1.88

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
29 Jun 2023	HKD0.499	30 Nov -0001	30 Nov -0001	30 Nov -0001
02 Jun 2023	HKD0.450	30 Nov -0001	30 Nov -0001	30 Nov -0001
02 Jun 2021	HKD0.242	30 Nov -0001	30 Nov -0001	30 Nov -0001
27 May 2020	HKD0.219	31 Mar 2020	28 May 2020	10 Jul 2020
05 Jun 2019	HKD0.341	26 Mar 2019	06 Jun 2019	08 Jul 2019
30 May 2018	HKD0.246	22 Mar 2018	31 May 2018	03 Jul 2018
15 Nov 2017	HKD0.118	24 Aug 2017	16 Nov 2017	15 Dec 2017
13 Jun 2017	HKD0.229	22 Mar 2017	14 Jun 2017	17 Jul 2017
14 Nov 2016	HKD0.229	22 Aug 2016	15 Nov 2016	15 Dec 2016

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
1821.HK	Ex Dividend Junior	2023-09-07	Semi-Annually	0.00%
0163.HK	Ex Dividend Junior	2023-09-26	Semi-Annually	0.00%
9983.HK	Ex Dividend Junior	2023-09-18	Semi-Annually	0.00%
1268.HK	Ex Dividend Knight	2023-09-20	Semi-Annually	0.00%
3600.HK	Ex Dividend Knight	2023-09-12	Annually	0.00%
0817.HK	Ex Dividend Junior	2023-09-18	Semi-Annually	0.00%
2003.HK	Ex Dividend Junior	2023-10-17	Annually	0.00%
0375.HK	Ex Dividend Knight	2023-09-27	Annually	0.00%
1516.HK	Ex Dividend Junior	2023-09-27	Annually	0.00%
0035.HK	Ex Dividend Knight	2023-09-05	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0117	1.500	9.77	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0158	1.200	9.47	10.00	[0 - 0.3]
returnOnEquityTTM	0.0877	1.500	-0.136	-0.205	[0.1 - 1]
payoutRatioTTM	1.470	-1.000	10.00	-10.00	[0 - 1]
currentRatioTTM	1.074	0.800	9.63	7.71	[1 - 3]
quickRatioTTM	0.615	0.800	-1.089	-0.871	[0.8 - 2.5]
cashRatioTTM	0.242	1.500	9.77	10.00	[0.2 - 2]
debtRatioTTM	0.481	-1.500	1.987	-2.98	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	-0.894	2.00	-0.298	-0.596	[0 - 30]
freeCashFlowPerShareTTM	-1.272	2.00	-0.636	-1.272	[0 - 20]
debtEquityRatioTTM	2.61	-1.500	10.00	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.0655	1.000	-2.24	-2.24	[0.2 - 0.8]
operatingProfitMarginTTM	0.0246	1.000	-1.508	-1.508	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.0618	1.000	-1.455	-1.455	[0.2 - 2]
assetTurnoverTTM	1.356	0.800	4.29	3.43	[0.5 - 2]
Total Score				5.24

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	16.83	1.000	8.40	0	[1 - 100]
returnOnEquityTTM	0.0877	2.50	-0.0877	-0.205	[0.1 - 1.5]
freeCashFlowPerShareTTM	-1.272	2.00	-0.424	-1.272	[0 - 30]
dividendYielPercentageTTM	4.12	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.894	2.00	-0.298	-0.596	[0 - 30]
payoutRatioTTM	1.470	1.500	10.00	-10.00	[0 - 1]
pegRatioTTM	2.95	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.0219	1.000	-3.05	0	[0.1 - 0.5]
Total Score				3.37

Charmacy Pharmaceutical Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Charmacy Pharmaceutical

Charmacy Pharmaceutical Co., Ltd. engages in the trading of pharmaceutical products in the People's Republic of China. The company offers western medicines, Chinese patent medicines, healthcare products, and related consulting services to downstream distributors and terminal chemists. It also operates Charmacy e-Medicine, a B2B e-commerce platform to place orders online and make inquiries and payments. The company was formerly known as Chuangmei Pharmaceutical Co., Ltd. and changed its name to Charmacy Pharmaceutical Co., Ltd. in July 2016. Charmacy Pharmaceutical Co., Ltd. was incorporated in 1984 and is headquartered in Shantou, the People's Republic of China.